Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alan Marc Gillinov

Thoracic Surgery (Cardiothoracic Vascular Surgery) Cleveland, OH Medical Doctor

NPI 1619931094 CMS profile 118369

9500 Euclid Ave, Cleveland, OH 44195

Open in the dashboard

General payments

$926,077

355 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$95,996 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Alan Marc Gillinov of Cleveland, OH is reported in the CMS Open Payments database as having received $926,077 across 355 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $95,996 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $125,663 62
2024 General $356,512 60
2023 General $67,721 28
2022 General $91,713 52
2021 General $65,560 18
2020 General $89,064 35
2019 General $129,844 100

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alan Marc Gillinov
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Alan Marc Gillinov were reported at $125,663. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Alan Marc Gillinov Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $129,844 $886 $178–$3,167 $163
2020 $89,064 $341 $108–$1,605 $114
2021 $65,560 $453 $125–$1,886 $132
2022 $91,713 $695 $180–$2,566 $149
2023 $67,721 $745 $205–$2,662 $160
2024 $356,512 $799 $214–$2,967 $164
2025 $125,663 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ClearFlow, Inc. $405,400 58 payments
  2. Edwards Lifesciences Corporation $308,952 101 payments
  3. Atricure, Inc. $85,433 102 payments
  4. Baxter Healthcare $59,403 23 payments
  5. Abbott Laboratories $22,170 29 payments
  6. CryoLife, Inc. $17,828 10 payments
  7. Medtronic Vascular, Inc. $11,659 7 payments
  8. Medtronic, Inc. $7,155 7 payments
  9. Corcym Inc $3,989 5 payments
  10. Intuitive Surgical, Inc. $1,046 5 payments
  11. Other $3,042 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $629,000 121 payments
  2. Acquisitions $223,082 1 payment
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,968 11 payments
  4. Travel and Lodging $18,195 77 payments
  5. Food and Beverage $9,532 139 payments
  6. Honoraria $8,300 3 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $7,000 3 payments
Products named General payments · program years 2019–2025
  1. Pleuraflow System with FlowGlide $235,400 26 payments
  2. PleuraFlow Cardiovascular $110,000 21 payments
  3. PleuraFlow Cardiovascular $60,000 11 payments
  4. TISSEEL $57,173 11 payments
  5. ATRICURE SYNERGY ABLATION SYSTEM $30,037 40 payments
  6. EPIC $17,443 25 payments
  7. SYNERGY ABLATION SYSTEM $16,972 25 payments
  8. On-X $11,828 6 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $11,577 13 payments
  10. Simulus $5,080 2 payments
  11. Other $34,512 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$301,057

Medicare's payments for the services billed

Medicare patients

122

Average age 72

Services billed

345

42 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 70%
Ischemic heart disease 61%
Arthritis 48%
Heart failure 45%
Cancer 16%
COPD 15%
Chronic kidney disease 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

355 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record